These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20023696)

  • 21. vFLIP-regulated competing endogenous RNA (ceRNA) networks targeting lytic induction for KSHV-associated malignancies.
    Sheng L; Chen C; Chen Y; He Y; Zhuang R; Gu Y; Yan Q; Li W; Lu C
    J Med Virol; 2022 Jun; 94(6):2766-2775. PubMed ID: 35149992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.
    Punj V; Matta H; Chaudhary PM
    PLoS One; 2012; 7(5):e37498. PubMed ID: 22624040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation.
    Sun Q; Matta H; Lu G; Chaudhary PM
    Oncogene; 2006 May; 25(19):2717-26. PubMed ID: 16418726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein, vFLIP, from the viral genome compromises the activation of STAT1-responsive cellular genes and spindle cell formation in endothelial cells.
    Alkharsah KR; Singh VV; Bosco R; Santag S; Grundhoff A; Konrad A; Stürzl M; Wirth D; Dittrich-Breiholz O; Kracht M; Schulz TF
    J Virol; 2011 Oct; 85(19):10375-88. PubMed ID: 21795355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene regulation and functional alterations induced by Kaposi's sarcoma-associated herpesvirus-encoded ORFK13/vFLIP in endothelial cells.
    Sakakibara S; Pise-Masison CA; Brady JN; Tosato G
    J Virol; 2009 Mar; 83(5):2140-53. PubMed ID: 19091861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling.
    Choi HS; Jain V; Krueger B; Marshall V; Kim CH; Shisler JL; Whitby D; Renne R
    PLoS Pathog; 2015; 11(11):e1005255. PubMed ID: 26545119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.
    Thurau M; Marquardt G; Gonin-Laurent N; Weinländer K; Naschberger E; Jochmann R; Alkharsah KR; Schulz TF; Thome M; Neipel F; Stürzl M
    J Virol; 2009 Jan; 83(2):598-611. PubMed ID: 18987137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis.
    Chandrasekharan JA; Huang XM; Hwang AC; Sharma-Walia N
    J Virol; 2016 Dec; 90(24):11020-11031. PubMed ID: 27681120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
    Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
    J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generation of a KSHV K13 deletion mutant for vFLIP function study.
    Wang F; Guo Y; Li W; Lu C; Yan Q
    J Med Virol; 2018 Apr; 90(4):753-760. PubMed ID: 29244209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IkappaB kinase complex to selectively activate NF-kappaB without JNK activation.
    Matta H; Mazzacurati L; Schamus S; Yang T; Sun Q; Chaudhary PM
    J Biol Chem; 2007 Aug; 282(34):24858-65. PubMed ID: 17597077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An NF-kappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia.
    Martin D; Galisteo R; Ji Y; Montaner S; Gutkind JS
    Oncogene; 2008 Mar; 27(13):1844-52. PubMed ID: 17934524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells.
    Lagos D; Trotter MW; Vart RJ; Wang HW; Matthews NC; Hansen A; Flore O; Gotch F; Boshoff C
    Blood; 2007 Feb; 109(4):1550-8. PubMed ID: 17047149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modified Cross-Linking, Ligation, and Sequencing of Hybrids (qCLASH) Identifies Kaposi's Sarcoma-Associated Herpesvirus MicroRNA Targets in Endothelial Cells.
    Gay LA; Sethuraman S; Thomas M; Turner PC; Renne R
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation.
    Tamanaha-Nakasone A; Uehara K; Tanabe Y; Ishikawa H; Yamakawa N; Toyoda Z; Kurima K; Kina S; Tsuneki M; Okubo Y; Yamaguchi S; Utsumi D; Takahashi K; Arakawa H; Arasaki A; Kinjo T
    Sci Rep; 2019 Apr; 9(1):6416. PubMed ID: 31015491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. vFLIP from KSHV inhibits anoikis of primary endothelial cells.
    Efklidou S; Bailey R; Field N; Noursadeghi M; Collins MK
    J Cell Sci; 2008 Feb; 121(Pt 4):450-7. PubMed ID: 18211958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KSHV vFLIP is essential for the survival of infected lymphoma cells.
    Guasparri I; Keller SA; Cesarman E
    J Exp Med; 2004 Apr; 199(7):993-1003. PubMed ID: 15067035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.